These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38581547)

  • 1. Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia.
    Meloni A; Pistoia L; Ricchi P; Bagnato S; Longo F; Messina G; Bagnato S; Rossi V; Renne S; Righi R; Fina P; Positano V; Cademartiri F
    Ann Hematol; 2024 Jun; 103(6):1887-1896. PubMed ID: 38581547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia.
    Meloni A; Pistoia L; Ricchi P; Putti MC; Gamberini MR; Cuccia L; Messina G; Massei F; Facchini E; Righi R; Renne S; Peritore G; Positano V; Cademartiri F
    J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.
    Meloni A; Pistoia L; Ricchi P; Longo F; Cecinati V; Sorrentino F; Cuccia L; Corigliano E; Rossi V; Righi R; Fina P; Renne S; Barbuto L; Positano V; Cademartiri F
    Radiol Med; 2024 Jun; 129(6):879-889. PubMed ID: 38683500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
    Ricchi P; Meloni A; Spasiano A; Neri MG; Gamberini MR; Cuccia L; Caruso V; Gerardi C; D'Ascola DG; Rosso R; Campisi S; Rizzo M; Terrazzino F; Vangosa AB; Chiodi E; Missere M; Mangione M; Positano V; Pepe A
    Am J Hematol; 2015 Nov; 90(11):1008-12. PubMed ID: 26228763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-thalassemia intermedia: a clinical perspective.
    Musallam KM; Taher AT; Rachmilewitz EA
    Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a013482. PubMed ID: 22762026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac involvement by CMR in different genotypic groups of thalassemia major patients.
    Pistoia L; Meloni A; Salvadori S; Spasiano A; Lisi R; Rosso R; Maggio A; D'Ascola DG; Cuccia L; Mangione M; Vallone A; Restaino G; Midiri M; Pepe A
    Blood Cells Mol Dis; 2019 Jul; 77():1-7. PubMed ID: 30878912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between genotype and disease complications in Egyptian patients with beta thalassemia: A Cross-sectional study.
    Hassan T; Zakaria M; Fathy M; Arafa M; El Gebaly S; Emam A; Abdel Wahab A; Shehab M; Salah H; Malek M; El Gerby K
    Sci Rep; 2018 Dec; 8(1):17730. PubMed ID: 30531823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.
    Amin SS; Jalal SD; Ali KM; Mohammed AI; Rasool LK; Osman TJ
    Biomed Res Int; 2020; 2020():2807120. PubMed ID: 32190657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
    Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-thalassemia.
    Galanello R; Origa R
    Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients.
    Meloni A; Pistoia L; Ricchi P; Longo F; Cecinati V; Sorrentino F; Borsellino Z; Bagnato S; Rossi V; Fina P; Riva A; Renne S; Peritore G; Positano V; Cademartiri F
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39200932
    [No Abstract]   [Full Text] [Related]  

  • 15. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network.
    Ricchi P; Meloni A; Grigoratos C; Toia P; Fina P; Pistoia L; Costantini S; Borsellino Z; Lisi R; Rocca M; Preziosi P; Midiri M; Pepe A
    Ann Hematol; 2019 Jun; 98(6):1333-1339. PubMed ID: 30891614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
    Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
    Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
    Wahidiyat PA; Liauw F; Sekarsari D; Putriasih SA; Berdoukas V; Pennell DJ
    Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.
    Musallam KM; Cappellini MD; Wood JC; Motta I; Graziadei G; Tamim H; Taher AT
    Haematologica; 2011 Nov; 96(11):1605-12. PubMed ID: 21791471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
    Tantiworawit A; Charoenkwan P; Hantrakool S; Choeyprasert W; Sivasomboon C; Sanguansermsri T
    Int J Hematol; 2016 Jun; 103(6):643-8. PubMed ID: 27052211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.